Alterations in the prothrombin coagulation pathway due to preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Reproductive Medicine

Background:

• Pregnancy involves significant physiological changes, including alterations in coagulation factors.
• Hypertensive disorders of pregnancy, such as preeclampsia and eclampsia, are associated with hemostatic system disturbances.

Purpose of the Study:

• To investigate circulating prothrombin levels in normal pregnancy and pregnancies with hypertensive complications.
• To assess the ratio of prothrombin antigen to activity (Ag/Act) as a potential biomarker in these conditions.

Main Methods:

• Plasma samples were collected from pregnant individuals with normal pregnancies, hypertension, preeclampsia, and eclampsia.
• Prothrombin antigen and activity levels were measured.
• The Ag/Act ratio was calculated and analyzed across different groups.

Main Results:

• Prothrombin antigen and activity levels were assessed in various pregnancy states.
• Hypertensive patients generally maintained normal Ag/Act ratios.
• A significant proportion of untreated preeclamptic patients and some eclamptic patients exhibited abnormal Ag/Act ratios.

Conclusions:

• The prothrombin Ag/Act ratio may serve as an indicator of coagulation abnormalities in preeclampsia and eclampsia.
• Monitoring this ratio could aid in understanding and managing these pregnancy complications.